Molecular basis for catecholaminergic neuron diversity
Open Access
- 7 September 2004
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (38) , 13891-13896
- https://doi.org/10.1073/pnas.0405340101
Abstract
Catecholaminergic neurons control diverse cognitive, motor, and endocrine functions and are associated with multiple psychiatric and neurodegenerative disorders. We present global gene-expression profiles that define the four major classes of dopaminergic (DA) and noradrenergic neurons in the brain. Hypothalamic DA neurons and noradrenergic neurons in the locus coeruleus display distinct group-specific signatures of transporters, channels, transcription, plasticity, axon-guidance, and survival factors. In contrast, the transcriptomes of midbrain DA neurons of the substantia nigra and the ventral tegmental area are closely related with <1% of differentially expressed genes. Transcripts implicated in neural plasticity and survival are enriched in ventral tegmental area neurons, consistent with their role in schizophrenia and addiction and their decreased vulnerability in Parkinson9s disease. The molecular profiles presented provide a basis for understanding the common and population-specific properties of catecholaminergic neurons and will facilitate the development of selective drugs.Keywords
This publication has 56 references indexed in Scilit:
- Synaptic adhesion moleculesCurrent Opinion in Cell Biology, 2003
- It could be habit forming: drugs of abuse and striatal synaptic plasticityPublished by Elsevier ,2003
- Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humansNature Genetics, 2002
- Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophreniaNature Neuroscience, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neuronsJournal of Neurobiology, 1999
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigraBrain Research, 1989
- Effects of Systemic Administration of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine to Mice on Tyrosine Hydroxylase, l‐3,4‐Dihydroxyphenylalanine Decarboxylase, Dopamine β‐Hydroxylase, and Monoamine Oxidase Activities in the Striatum and HypothalamusJournal of Neurochemistry, 1988
- Preservation of hypothalamic dopaminergic neurons in Parkinson's diseaseAnnals of Neurology, 1985